These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1670995)

  • 1. Allelotype study of primary hepatocellular carcinoma.
    Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
    Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
    Slagle BL; Zhou YZ; Butel JS
    Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of somatic heterozygosity in hepatocellular carcinoma.
    Walker GJ; Hayward NK; Falvey S; Cooksley WG
    Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.
    Emi M; Fujiwara Y; Nakajima T; Tsuchiya E; Tsuda H; Hirohashi S; Maeda Y; Tsuruta K; Miyaki M; Nakamura Y
    Cancer Res; 1992 Oct; 52(19):5368-72. PubMed ID: 1356616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Loss of heterozygosity in hepatocellular carcinoma].
    Takahashi K; Kudo J; Ishibashi H; Niho Y
    Nihon Rinsho; 1993 Feb; 51(2):370-4. PubMed ID: 8096550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion mapping of chromosome 16q in hepatocellular carcinoma.
    Piao Z; Park C; Kim JJ; Kim H
    Br J Cancer; 1999 May; 80(5-6):850-4. PubMed ID: 10360665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.
    Morita R; Saito S; Ishikawa J; Ogawa O; Yoshida O; Yamakawa K; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5817-20. PubMed ID: 1682036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
    Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China.
    Becker SA; Zhou YZ; Slagle BL
    Cancer Res; 1996 Nov; 56(21):5092-7. PubMed ID: 8895769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.
    Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
    Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.
    Takahashi K; Kudo J; Ishibashi H; Hirata Y; Niho Y
    Hepatology; 1993 May; 17(5):794-9. PubMed ID: 8387946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K
    Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.
    Nishimura T; Nishida N; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Cancer Genet Cytogenet; 2006 May; 167(1):57-65. PubMed ID: 16682288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.
    Bressac B; Kew M; Wands J; Ozturk M
    Nature; 1991 Apr; 350(6317):429-31. PubMed ID: 1672732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recessive genetic mechanisms in the oncogenesis of prostatic carcinoma.
    Bergerheim US; Collins VP; Ekman P; Kunimi K
    Scand J Urol Nephrol Suppl; 1991; 138():93-6. PubMed ID: 1686123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.